Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus infection: current status.

Ponsiano Ocama1, Christopher K Opio, William M Lee

  • 1Mulago Hospital, Kampala, Uganda.

The American Journal of Medicine
|December 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of viral and host factors in determining the outcome of HBV-associated acute liver failure.

Journal of translational medicine·2026
Same author

Care-seeking among hepatocellular carcinoma patients in Uganda: health system navigation and its impact on diagnosis and survival in a prospective case-cohort study.

BMJ public health·2026
Same author

Government health care worker training needs for intestinal schistosomiasis morbidity management.

PLoS neglected tropical diseases·2026
Same author

MASLD prevalence, incidence and global aspects.

Diabetologia·2026
Same author

Optimizing hepatitis B diagnosis for mothers in a low-resource setting: A field pilot of Xpert point-of-care viral load testing in Ugandan antenatal clinics.

PLOS global public health·2026
Same author

Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Hepatitis B virus infection impacts millions globally. While vaccines exist, new strategies are needed to combat the virus

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis B virus (HBV) infects over 400 million worldwide, with limited recent decline in prevalence despite vaccination.
  • HBV causes liver injury primarily through immune responses, not direct cell damage, though immunosuppression can increase viral replication and cytotoxicity.
  • Disease progression, including cirrhosis, is determined by the interplay between host immunity and viral replication dynamics.

Purpose of the Study:

  • To review the current understanding of Hepatitis B virus infection, including its pathogenesis, treatment, and prevention.
  • To highlight the impact of viral mutations and genotypes on clinical outcomes and treatment response.
  • To discuss challenges in managing HBV infection, particularly in complex cases like co-infections.

Main Methods:

Related Experiment Videos

  • Review of existing literature on Hepatitis B virus infection.
  • Analysis of viral factors, host immune responses, and clinical outcomes.
  • Evaluation of current therapeutic agents and vaccination strategies.

Main Results:

  • Viral replication, host immune response, mutations, and genotypes are key determinants of liver injury and disease progression.
  • Approved antiviral drugs effectively reduce HBV replication, inflammation, and fibrosis.
  • Hepatitis B vaccine reduces new infections, but wider use and behavioral changes are crucial for global prevalence reduction.

Conclusions:

  • Effective management of Hepatitis B virus infection requires a multifaceted approach, including vaccination, antiviral therapy, and behavioral modifications.
  • Ongoing research into viral mutations and host-pathogen interactions is essential for improving treatment outcomes.
  • Addressing challenges in complex HBV cases, such as co-infections, remains a priority for global health initiatives.